ATE347596T1 - Dna kodierend für einen humanen protonenabhängigen ionenkanal und deren verwendungen - Google Patents

Dna kodierend für einen humanen protonenabhängigen ionenkanal und deren verwendungen

Info

Publication number
ATE347596T1
ATE347596T1 AT98951141T AT98951141T ATE347596T1 AT E347596 T1 ATE347596 T1 AT E347596T1 AT 98951141 T AT98951141 T AT 98951141T AT 98951141 T AT98951141 T AT 98951141T AT E347596 T1 ATE347596 T1 AT E347596T1
Authority
AT
Austria
Prior art keywords
hasic3
proton
neurons
sensory
gated
Prior art date
Application number
AT98951141T
Other languages
English (en)
Inventor
Philippe Seguela
Kazimierz Babinski
Original Assignee
Univ Mcgill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mcgill filed Critical Univ Mcgill
Application granted granted Critical
Publication of ATE347596T1 publication Critical patent/ATE347596T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT98951141T 1997-10-29 1998-10-29 Dna kodierend für einen humanen protonenabhängigen ionenkanal und deren verwendungen ATE347596T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2219713 1997-10-29

Publications (1)

Publication Number Publication Date
ATE347596T1 true ATE347596T1 (de) 2006-12-15

Family

ID=4161708

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98951141T ATE347596T1 (de) 1997-10-29 1998-10-29 Dna kodierend für einen humanen protonenabhängigen ionenkanal und deren verwendungen

Country Status (7)

Country Link
EP (1) EP1025226B1 (de)
AT (1) ATE347596T1 (de)
AU (1) AU9732498A (de)
CA (1) CA2308014A1 (de)
DE (1) DE69836591T2 (de)
ES (1) ES2279583T3 (de)
WO (1) WO1999021981A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6287859B1 (en) * 1998-08-05 2001-09-11 Centre National De La Recherche Identification, functional expression and chromosal localization of a sustained human proton-gated cation channel
AU4910500A (en) 1999-05-19 2000-12-12 Neurosearch A/S Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
US6548270B1 (en) 2000-03-03 2003-04-15 Ortho-Mcneil Pharmaceutical, Inc. DNA encoding human acid-sensing ion channel BNaC4 (ASIC4)
CA2304494A1 (en) 2000-04-20 2001-10-20 Philippe Seguela A novel heteromultimeric ion channel receptor and uses thereof
US9371383B2 (en) 2012-01-31 2016-06-21 Regeneron Pharmaceuticals, Inc. Anti-ASIC1 antibodies and uses thereof
SI2809681T1 (sl) 2012-01-31 2019-04-30 Regeneron Pharmaceuticals, Inc. Protitelesa anti-asic1 in njihova uporaba

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9513180D0 (en) * 1995-06-28 1995-08-30 Univ London Ion channel
FR2759373B1 (fr) * 1997-02-11 2001-05-04 Centre Nat Rech Scient Nouveau canal cationique neuronal de mammifere sensible a l'acidite, son clonage et ses applications
EP0884386A1 (de) * 1997-05-30 1998-12-16 Synthelabo Natrium-Ionenkanäle Rezeptor

Also Published As

Publication number Publication date
CA2308014A1 (en) 1999-05-06
AU9732498A (en) 1999-05-17
EP1025226A1 (de) 2000-08-09
WO1999021981A1 (en) 1999-05-06
DE69836591T2 (de) 2007-09-20
ES2279583T3 (es) 2007-08-16
EP1025226B1 (de) 2006-12-06
DE69836591D1 (de) 2007-01-18

Similar Documents

Publication Publication Date Title
Dolphin et al. Presynaptic calcium channels: specialized control of synaptic neurotransmitter release
Rajakulendran et al. Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS
Cassano et al. Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease
Ahmad et al. Genomic organization of the human hairless gene (HR) and identification of a mutation underlying congenital atrichia in an Arab Palestinian family
Albrecht et al. The ABCA subfamily—gene and protein structures, functions and associated hereditary diseases
Klugbauer et al. Calcium channel α 2 δ subunits: Differential expression, function, and drug binding
Shafer et al. The D3 dopamine receptor in cellular and organismal function
Klammt et al. IGF1R mutations as cause of SGA
Beeson et al. Mutations affecting muscle nicotinic acetylcholine receptors and their role in congenital myasthenic syndromes
Ferguson et al. Why calcium-stimulated adenylyl cyclases?
Cox et al. Congenital insensitivity to pain: novel SCN9A missense and in‐frame deletion mutations
Finsterer et al. Nuclear and mitochondrial genes mutated in nonsyndromic impaired hearing
Bhat et al. Functional and biochemical consequences of disease variants in neurotransmitter transporters: a special emphasis on folding and trafficking deficits
Schaefer et al. Molecular cloning, functional expression and chromosomal localization of an amiloride-sensitive Na+ channel from human small intestine
Chen et al. Functional analysis of nonsynonymous single nucleotide polymorphisms in human SLC26A9
Chandran et al. Alsin and the molecular pathways of amyotrophic lateral sclerosis
ATE347596T1 (de) Dna kodierend für einen humanen protonenabhängigen ionenkanal und deren verwendungen
Zafra et al. Glycinergic transmission: glycine transporter GlyT2 in neuronal pathologies
Andrade et al. Proteolytic cleavage of the voltage‐gated Ca2+ channel α2δ subunit: structural and functional features
US6287859B1 (en) Identification, functional expression and chromosal localization of a sustained human proton-gated cation channel
Soleimani Expression, regulation and the role of SLC26 Cl−/HCO3− exchangers in kidney and gastrointestinal tract
Han et al. Tadr is an axonal histidine transporter required for visual neurotransmission in Drosophila
Barhanin et al. IKs, a slow and intriguing cardiac K+ channel and its associated long QT diseases
Mckeown et al. Molecular basis of inherited calcium channelopathies: role of mutations in pore‐forming subunits 1
Senin et al. Ca2+/recoverin dependent regulation of phosphorylation of the rhodopsin mutant R135L associated with retinitis pigmentosa

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties